CA2016656A1 - Inhibiteurs d'enzyme - Google Patents

Inhibiteurs d'enzyme

Info

Publication number
CA2016656A1
CA2016656A1 CA2016656A CA2016656A CA2016656A1 CA 2016656 A1 CA2016656 A1 CA 2016656A1 CA 2016656 A CA2016656 A CA 2016656A CA 2016656 A CA2016656 A CA 2016656A CA 2016656 A1 CA2016656 A1 CA 2016656A1
Authority
CA
Canada
Prior art keywords
amino acid
derivatives
hydroxy
peptide
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2016656A
Other languages
English (en)
Other versions
CA2016656C (fr
Inventor
Paul Cates Anderson
Yvan Guindon
Christiane Yoakim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Bio Mega Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Inc filed Critical Bio Mega Inc
Publication of CA2016656A1 publication Critical patent/CA2016656A1/fr
Application granted granted Critical
Publication of CA2016656C publication Critical patent/CA2016656C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002016656A 1989-06-06 1990-05-14 Inhibiteurs d'enzyme Expired - Fee Related CA2016656C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US362,171 1989-06-06
US07/362,171 US5212157A (en) 1989-06-06 1989-06-06 Enzyme inhibitors

Publications (2)

Publication Number Publication Date
CA2016656A1 true CA2016656A1 (fr) 1990-12-06
CA2016656C CA2016656C (fr) 2000-04-11

Family

ID=23424961

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002016656A Expired - Fee Related CA2016656C (fr) 1989-06-06 1990-05-14 Inhibiteurs d'enzyme

Country Status (7)

Country Link
US (1) US5212157A (fr)
EP (1) EP0401676B1 (fr)
JP (1) JPH0347196A (fr)
AT (1) ATE116995T1 (fr)
AU (1) AU646806B2 (fr)
CA (1) CA2016656C (fr)
DE (1) DE69015885T2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516784A (en) * 1991-08-13 1996-05-14 Schering Corporation Anti-HIV (AIDS) agents
EP0633881B1 (fr) * 1992-03-11 2003-10-29 Narhex Limited Derives amines d'hydrocarbures a substitution oxo et hydroxy
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5236934A (en) * 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
US5693815A (en) * 1993-01-17 1997-12-02 Schering Corporation Peptides
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
US5932550A (en) * 1995-06-30 1999-08-03 Japan Energy Corporation Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
US5849691A (en) * 1996-02-20 1998-12-15 The United States Of America As Represented By The Department Of Health And Human Services Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
US6291432B1 (en) 1996-12-27 2001-09-18 Japan Energy Corporation Tripeptide compounds and anti-AIDS medicine
US6783947B1 (en) 1999-09-09 2004-08-31 Dade Behring Marburg Gmbh Protecting groups for biological labeling
JP4459629B2 (ja) 2002-04-12 2010-04-28 メルク エンド カムパニー インコーポレーテッド 二環式アミド
TW201402613A (zh) 2012-06-19 2014-01-16 必治妥美雅史谷比公司 Ｉａｐ拮抗劑

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1258748A (fr) * 1981-10-08 1989-08-22 Daniel F. Veber Peptides inhibiteurs de la renine
US4680284A (en) * 1985-01-23 1987-07-14 Abbott Laboratories Modified phenylalanine peptidylaminodiols
DE3538749A1 (de) * 1985-10-31 1987-05-07 Merck Patent Gmbh Peptide
JPS63501364A (ja) * 1985-11-15 1988-05-26 ジ・アップジョン・カンパニ− Ｓ−アリ−ル−ｄ−またはｌ−またはｄｌ−システイニル、３−（アリ−ルチオ）乳酸または３−（アリ−ルチオ）アルキル基を含有する新規レニン阻害ポリペプチド同族体
US4894437A (en) * 1985-11-15 1990-01-16 The Upjohn Company Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
DE3627877A1 (de) * 1986-07-30 1988-02-04 Hoechst Ag Renin-hemmende di- und tripeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
HU204285B (en) * 1986-10-31 1991-12-30 Pfizer Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them
BE1002213A5 (fr) * 1987-04-23 1990-10-16 Sandoz Sa Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
US5342922A (en) * 1989-03-08 1994-08-30 Washington University Inhibitors of retroviral protease

Also Published As

Publication number Publication date
AU646806B2 (en) 1994-03-10
US5212157A (en) 1993-05-18
EP0401676B1 (fr) 1995-01-11
DE69015885T2 (de) 1995-06-08
ATE116995T1 (de) 1995-01-15
DE69015885D1 (de) 1995-02-23
CA2016656C (fr) 2000-04-11
AU5628990A (en) 1990-12-13
JPH0347196A (ja) 1991-02-28
EP0401676A1 (fr) 1990-12-12

Similar Documents

Publication Publication Date Title
CA2016656A1 (fr) Inhibiteurs d'enzyme
CA2336597A1 (fr) Peptides inhibiteurs de l'hepatite c
AU653972B2 (en) HIV protease inhibitors
ES2182852T3 (es) Derivados de prolinamida.
CA2016663A1 (fr) Derives peptidiques inhibiteurs d'enzyme
CA2081970A1 (fr) Utilisation d'agents inhibant la protease du vih pour le traitement du sida
CA2131185A1 (fr) Derives substitues de l'acide pipecolinique utilises comme inhibiteurs de la protease du vih
AU5162796A (en) Novel peptide derivatives
AU5628596A (en) Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
CA2092653A1 (fr) Utilisation de derives substitues de pyrrolidine comme inhibiteurs de la protease du vih
WO1999058526A8 (fr) Nouveaux derives d'acide 2,5-pyridinecarboxylique
CA2010035A1 (fr) Derives de proline
CA2036398A1 (fr) Agents d'inhibition de la protease du vih
CA2373880A1 (fr) Derives de l'isoquinoline ou leurs sels
CA2036413A1 (fr) Inhibiteurs de la protease du vih
AU1855088A (en) Treating agent for heart failure
NO972905L (no) Tienoksasinon-derivater anvendelige som antivirusmidler
CA2202992A1 (fr) Derives d'acide propenoique substitues par un heterocycle utilises comme antagonistes de nmda
DK0832085T3 (da) Phosphinsyrederivater med metallopeptidaseinhiberende aktivitet
NO981093L (no) 2-£2£(2-hydroksyetyl)amino|etyl|-5-££2-metylamino)etyl|amino|-indazolo£4,3-gh|isokinolin-6(2H)-on som antitumor middel
ES2132255T3 (es) Nuevos compuestos de flavilio farmaceuticamente activos.
CA2282254A1 (fr) Hydroxyazepanes servant d'inhibiteurs de la glycosidase et de la vih-protease
NO991772L (no) Overgangsmetallsalter av polypeptid samt fremgangsmÕte ved °king av anti-HIV-aktivitet av slikt polypeptid
TW360630B (en) A secoaporphine compounds on arrhythmia
EP1840134A3 (fr) Dérivés du GLP-1

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed